Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Data obtained for the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6).

Bacterial reverse mutation assay (Ames test / OECD 471): negative with and without metabolic activation

An in vitro cytogenicity study in mammalian cells or an in vitro micronucleus study was not conducted because adequate data from in vivo cytogenicity tests are available.

No data are available for the target substance regarding in vitro mammalian cell gene mutation. Therefore, read-across from the structural analogue substance sodium dodecyl sulfate (CAS 151-21-3) has been applied.

In vitro mammalian cell gene mutation assay (MLA / OECD 476): negative with and without metabolic activation

Link to relevant study records

Referenceopen allclose all

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
16 Sept - 25 Sept 1987
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Remarks:
No E. coli strain and/or S. typhimurium TA 102 tested
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
26 May 1983
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
21 July 1997
Deviations:
yes
Remarks:
No E. coli strain and/or S. typhimurium TA 102 tested
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay
Target gene:
his operon
Species / strain / cell type:
S. typhimurium, other: TA 98, TA 100, TA 1535, TA 1537, and TA 1538
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254.
Test concentrations with justification for top dose:
First experiment: 8, 40, 200, 1000, and 5000 µg/plate with and without metabolic activation
Second experiment: 1.6, 8, 40, 200, and 1000 µg/plate with and without metabolic activation
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: water
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Remarks:
water
Positive controls:
yes
Positive control substance:
9-aminoacridine
sodium azide
other: 4-Nitro-o-phenylen diamine (NPD; 40 µg/plate; - and +S9; TA 1538 and TA 98) 2-Amino anthracene (AA; - and +S9, all strains)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation, both experiments)

DURATION
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: 3 replications each in 2 independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: Inspection of the bacterial background lawn
Evaluation criteria:
The test material may be considered positive in this test system if the following criteria are met: For the test item to be considered mutagenic, two-fold (or more) increases in mean revertant numbers must be observed at two consecutive dose levels or at the highest practicable dose level only. In addition, there must be evidence of a dose-response relationship showing increasing numbers of mutant colonies with increasing dose levels.
All cultures must demonstrate the characteristic mean number of spontaneous revertants in the vehicle controls.
Statistics:
Mean values and standard deviation were calculated.
Key result
Species / strain:
S. typhimurium, other: TA 98, TA 100, TA 1535, TA 1537, and TA 1538
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
refer to detailed tables in section "Any other information on results incl. tables"
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid

Table 1: Test Results of Experiment 1 

EXPERIMENT 1 (Standard Plate Test, SPT)

S9-Mix

Without

Test item (µg/plate)

TA 1535

TA 100

TA 1537

TA 1538

TA 98

NC

14.8 ± 2.5

165.8 ± 8.6

8.3 ± 1.6

19.6 ± 3.3

19.6 ± 3.7

5000

##

##

##

##

8.6 ± 2.0

1000

##

51.3 ± 11.2

##

##

16.6 ± 3.5

200

10.3 ± 3.0

98.6 ± 10.7

##

17.3 ± 3.5

20.3 ± 2.0

40

15.3 ± 5.1

137.6 ± 17.9

8.3 ± 1.1

21.6 ± 1.1

20.6 ± 6.4

8

15.3 ± 2.8

164.6 ± 8.3

10.3 ± 2.0

21.0 ± 1.7

23.3 ± 5.6

sodium azide

1012.0 ± 83.5

916.0 ± 51.5

--

--

--

2-Amino anthracene

17.0 ± 4.0

188.3 ± 3.0

11.0 ± 2.0

36.0 ± 4.5

27.3 ± 5.1

9-Amino acridine

--

--

1613.6 ± 193.9

--

--

4-Nitro-o-phenylen diamine

--

--

--

1556.6 ± 202.5

1313.3 ± 36.2

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 1535

TA 100

TA 1537

TA 1538

TA 98

NC

13.8 ± 2.9

106.3 ± 16.8

8.3 ± 2.4

20.8 ± 4.4

24.1 ± 4.0

5000

##

##

##

##

12.6 ± 2.5

1000

10.0 ± 2.8

54.6 ± 14.1

##

12.0 ± 1.4

24.0 ± 1.7

200

9.6 ± 0.57

93.6 ± 15.0

7.0 ± 1.7

21.3 ± 2.0

22.3 ± 3.2

40

13.3 ± 2.5

136.3 ± 21.5

10.6 ± 1.5

21.0 ± 1.0

30.3 ± 9.8

8

15.3 ± 1.5

156.6 ± 26.8

11.3 ± 2.0

25.6 ± 8.5

27.3 ± 6.5

sodium azide

293.6 ± 19.2

372.3 ± 50.0

--

--

--

2-Amino anthracene

245.6 ± 25.1

1025.3 ± 58.2

143.0 ± 41.7

1494.6 ± 45.3

1011.3 ± 127.9

9-Amino acridine

--

--

590.0 ± 46.8

--

--

4-Nitro-o-phenylen diamine

--

--

--

800.3 ± 138.2

735.3 ± 121.5

NC = Negative/Vehicle Control

##: Complete inhibition of bacterial growth

--: Not tested

 

Table 2: Test Results of Experiment 2

EXPERIMENT 2 (Standard Plate Test, SPT)

S9-Mix

Without

Test item (µg/plate)

TA 1535

TA 100

TA 1537

TA 1538

TA 98

NC

13.6 ± 1.2

158.3 ± 20.3

11.3 ± 2.3

20.6 ± 1.0

33.5 ± 3.4

1000

##

48.0 ± 9.8

##

##

27.0 ± 3.0

200

9.6 ± 1.5

115.6 ± 20.4

##

19.0 ± 1.0

28.0 ± 4.3

40

12.6 ± 3.2

120.0 ± 18.5

11.0 ± 2.0

21.0 ± 2.0

33.3 ± 5.5

8

15.6 ± 2.3

149.3 ± 17.6

13.6 ± 2.3

21.6 ± 1.5

36.0 ± 2.6

1.6

15.3 ± 0.57

159.0 ± 13.1

13.0 ± 2.6

24.3 ± 1.5

31.6 ± 3.7

sodium azide

1037.0 ± 77.1

1017.6 ± 20.1

--

--

--

2-Amino anthracene

18.0 ± 2.6

197.3 ± 12.0

16.6 ± 1.5

41.0 ± 8.7

39.6 ± 9.6

9-Amino acridine

--

--

1250.3 ± 341.0

--

--

4-Nitro-o-phenylen diamine

--

--

--

1753.3 ± 323.4

1284.3 ± 72.7

S9-Mix

With

 

 

 

 

 

 

Test item (µg/plate)

TA 1535

TA 100

TA 1537

TA 1538

TA 98

NC

19.5 ± 4.0

191.0 ± 16.9

12.1 ± 1.7

29.5 ± 3.8

33.5 ± 7.3

1000

13.3 ± 2.0

83.6 ± 10.1

##

##

29.3 ± 3.2

200

17.6 ± 3.0

159.0 ± 12.0

8.6 ± 3.5

25.6 ± 4.1

33.3 ± 7.7

40

21.3 ± 3.7

196.6 ± 8.7

13.0 ± 1.7

29.3 ± 3.5

31.0 ± 6.0

8

20.6 ± 1.5

206.3 ± 11.0

14.6 ± 2.0

29.3 ± 2.0

36.6 ± 6.1

1.6

24.6 ± 2.5

200.6 ± 8.0

14.3 ± 2.5

31.3 ± 4.5

34.0 ± 2.6

sodium azide

1095.0 ± 74.8

1059.0 ± 119.4

--

--

--

2-Amino anthracene

203.6 ± 18.5

1669.3 ± 389.4

541.3 ± 56.4

1297.6 ± 109.9

1509.3 ± 36.6

9-Amino acridine

--

--

1583.3 ± 134.9

--

--

4-Nitro-o-phenylen diamine

--

--

--

1437.0 ± 44.0

957.3 ± 49.5

NC = Negative/Vehicle Control

##: Complete inhibition of bacterial growth

--: Not tested

Conclusions:
Interpretation of results: negative
Endpoint:
in vitro gene mutation study in mammalian cells
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Justification for type of information:
Refer to the Category Approach Justification document provided in IUCLID6 Section 13
Reason / purpose for cross-reference:
read-across source
Key result
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
-S9: 70, 80 and 90 µg/mL; +S9: 95 µg/mL
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Remarks on result:
other: Source, key, 151-21-3, 1988
Conclusions:
Interpretation of results: negative
Executive summary:

The potential of gene mutations in mammalian cells of the target substance is estimated based on an adequate and reliable in vitro gene mutation study in mouse lymphoma L5178Y cells of a structural analogue source substance. Experiments have been performed both in the presence as well as in the absence of metabolic activation. All results obtained are negative, i.e., no gene mutation in mouse lymphoma L5178Y cells

was observed. Therefore, no hazard with regard to gene mutation in mammalian cells is identified for the target substance. As explained in the category justification, the differences in molecular structure between the target and the source substances are unlikely to lead to differences in gene mutation in mammalian cells.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Genetic toxicity in vivo

Description of key information

No data are available for the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6). Therefore, read-across from structural analogue substances has been applied.

Mammalian Bone Marrow Chromosome Aberration Test (CA / OECD 475): negative

Read-across from source substance sulfuric acid, mono-C12-15-alkyl esters, sodium salts (CAS 68890-70-0)

Mammalian Erythrocyte Micronucleus Test (MNT / OECD 474): negative

Read-across from source substance sulfuric acid, mono-C16-18-alkyl esters, sodium salts (CAS 68955-20-4)

Link to relevant study records
Reference
Endpoint:
genetic toxicity in vivo, other
Remarks:
in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration and erythrocyte micronucleus
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Remarks:
Summary of available data used for the endpoint assessment of the target substance
Adequacy of study:
weight of evidence
Justification for type of information:
Refer to the Category Approach Justification document provided in IUCLID6 Section 13
Reason / purpose for cross-reference:
read-across source
Reason / purpose for cross-reference:
read-across source
No. of animals per sex per dose:
6
Key result
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
not applicable
Positive controls validity:
valid
Remarks on result:
other: Source, WoE, 68890-70-0, 1976c

The key result is further supported by an additional study accounted for in a Weight-of-Evidence approach:

Source, WoE, 90583 -18 -9, 1987d: mouse (m/f): negative for genotoxicity after oral gavage application of 400, 2000 and 4000 mg/kg bw

Conclusions:
Interpretation of results: negative
Executive summary:

The potential for in vivo mammalian chromosome aberration of the target substance is estimated based on two adequate and reliable in vivo studies of structural analogue source substances. Feeding of male and female rats with sulfuric acid, mono-C12-15-alkyl esters, sodium salts (CAS 68890-70-0) at 1.13% (nominal in diet) for 90 days did not induce chromosome aberrations in bone marrow. Moreover, a single oral exposure by gavage with 400, 2000 and 4000 mg/kg bw/day sulfuric acid, mono-C12-14-alkyl esters, compds. with triethanolamine (CAS 90583-18-9) did not induce erythrocyte micronuclei in male and female mice. Therefore, based on read-across no hazard with regard to in vivo mammalian chromosome aberration is identified for the target substance. As explained in the category justification, the differences in molecular structure between the target and the source substances are unlikely to lead to differences in the genotoxic potential.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

General considerations

The lack of mutagenic activity for the alkyl sulfates (AS) category is predictable based on structural and mechanistic considerations. Mutagens are chemicals that either contain highly reactive electrophilic centers capable of interacting with nucleophilic sites on DNA (direct acting agents) or can be metabolised to highly reactive electrophiles. The chemical structures represented by the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) and AS in general, incl. the structural analogues used for read-across, do not contain electrophilic functional groups or functional groups capable of being metabolised to electrophiles. AS with fully saturated carbon chains are not metabolised to reactive electrophiles. The consistent lack of mutagenic activity observed for all AS is consistent with these mechanistic predictions.

Genetic toxicity in vitro

Genetic toxicity in vitro has been investigated with the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) only with respect to gene mutation in bacteria. No studies regarding cytogenicity and gene mutation in mammalian cells are available. Therefore, these endpoints are covered by read-across from structurally related alkyl sulfates (AS). The possibility of a read-across from other alkyl sulfates in accordance with Regulation (EC) No. 1907/2006, Annex XI 1.5 “Grouping of substances and read-across approach” was assessed. In Annex XI 1.5 it is given that a read-across approach is possible for substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity. The AS reported within the AS category show structural similarity. The most important common structural feature of the category members is the presence of a predominantly linear aliphatic hydrocarbon chain with a polar sulfate group, neutralised with a counter ion. This structural feature confers the surfactant properties of the alkyl sulfates. The surfactant property of the members of the AS category in turn represents the predominant attribute in mediating effects on mammalian health. Therefore, the members of the AS category have similar physicochemical, environmental and toxicological properties, validating the read-across approach within the category. The approach of grouping different AS for the evaluation of their effects on human health and the environment was also made by the OECD in the SIDS initial assessment profile [1] and by a voluntary industry programme carrying out Human and Environmental Risk Assessments (HERA [2]), further supporting the read-across approach between structurally related AS.

 

Mutagenicity in bacteria

The potential of the target substance to induce gene mutation in bacterial cells was tested according to OECD Guideline 471 (Ames test) under GLP conditions (BASF, 1987c). Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537, and TA 1538 were treated with sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) in the presence and absence of metabolic activation. The tester strains TA 102 or E.coli were not used in the study. In this study the dose range was 8, 40, 200, 1000, and 5000 µg/plate in the first experiment and 1.6, 8, 40, 200, and 1000 µg/plate in the second experiment. Vehicle (water) and positive controls yielded the expected results, thus validating the study and the efficiency of the metabolising system. Cytotoxicity was observed in the presence and absence of metabolic activation at and above 200 µg/plate. No increase in the number of revertant colonies was noted in any tester strain at any test item concentration, either in the present or the absence of metabolic activtion. Therefore, sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) is considered not to be genotoxic in the Ames test.

Cytogenicity / chromosome aberration / micronucleus study in mammalian cells

An in vitro cytogenicity study in mammalian cells or an in vitro micronucleus study was not conducted because adequate data from in vivo cytogenicity tests are available. The in vivo studies will be discussed further down.

 

Mutagenicity in mammalian cells

The mutagenicity of sodium dodecyl sulfate (CAS 151-21-3) in a mammalian cell line was investigated similar to OECD Guideline 476 using the mouse lymphoma L5178Y cells with and without metabolic activation (McGregor, 1988). The test concentrations were 3.125, 6.25, 10, 12.5, 20, 25, 30, 40, 50, 55, 60, 65, 70, 80 and 100 µg/mL without and 50, 55, 60, 65, 70, 75, 80, 85, 90 and 95 µg/mL with metabolic activation. Results achieved with the negative (untreated), vehicle (DMSO) and positive controls were valid. Cytotoxicity was observed in presence and absence of metabolic activation while no genotoxicity was observed under both circumstances for the test item.

 

Genotoxicity in vivo

The potential of sulfuric acid, mono-C12-15-alkyl esters, sodium salts (CAS 68890-70-0, analytical purity approx. 30%) to induce in vivo chromosomal aberration was assessed in a study conducted similar to OECD Guideline 475 in rats (Unilever, 1976c). The test substance was administered via feed at a dose of 1.13% for a period of 90 days to 6 animals per sex and dose and bone marrow was sampled thereafter. Results achieved with the vehicle (DMSO) and positive controls were valid. No signs of toxicity were noted. As no enhanced chromosome aberrations were observed in this micronucleus test the test substance was considered to be not clastogenic.

 

The potential of sulfuric acid, mono-C12-14-alkyl esters, compds. with triethanolamine (CAS 90583-18-9, analytical purity ca. 41%) to induce micronuclei in vivo was assessed in a study conducted according to OECD Guideline 474 with CFW-1 mouse (BASF, 1987d). The test substance was administered via gavage at doses of 400, 2000 and 4000 mg/kg bw to 7 animals per sex and dose. Bone marrow was sampled 24 h (400 and 2000 mg/kg bw) and 24, 48 and 72 h (4000 mg/kg bw) after gavage. Results achieved with the vehicle (water) and positive controls were valid. No signs of toxicity were noted. As no enhanced chromosome aberrations were observed in this micronucleus test the test substance was considered to be not clastogenic.

 

Conclusion

In conclusion, neither the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) nor any of the structural analogues used for read-across did not show any genotoxic potential in studies performed in vitro on bacterial and mammalian cells as well as in two independent in vivo studies. This is supported by the conclusions of the HERA Draft report on alkyl sulfates (AS) “AS are not genotoxic, mutagenic or carcinogenic…” and the conclusions of the SIDS initial assessment profile “Alkyl sulfates of different chain length and with different counter ions were not mutagenic in standard bacterial and mammalian cell systems [...]. There was also no indication for a genotoxic potential of alkyl sulfates in various in vivo studies on mice […]”.

 

[1] SIDS initial assessment profile, (2007); http://www.aciscience.org/docs/Alkyl_Sulfates_Final_SIAP.pdf

[2] (HERA Draft report, 2002); http://www.heraproject.com/files/3-HH-04-%20HERA%20AS%20HH%20web%20wd.pdf

Justification for classification or non-classification

The available data on genetic toxicity from studies performed in vitro and in vivo using the target substance sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, magnesium salts (CAS 90583-23-6) as well as several structural analogue substances do not meet the criteria for classification according to Regulation (EC) No. 1272/2008 (CLP) and are, therefore, conclusive but not sufficient for classification. Based on own data and on read-across, the target substance is not classified for mutagenicity.